Swiss biotech Covagen has extended its CHF 42m series-B funding round, raised in December, to procure a further CHF 2.9m from Baxter Ventures.
Transaction also financed with a €10m senior debt from LCL, BNP Paribas, Bred Banque Populaire and CIC
GP acquires a 49% stake in the company for €1.06bn, while the reminder is retained by current owner Atlantia
LDC invested £20m in Mitrefinch in 2016 for a minority stake and has supported the company in doubling revenues
Omega managing director Claudio Nessi and principal Francesco Draetta will join the company's board